Check-Cap (MBAI) Net Income towards Common Stockholders (2014 - 2024)
Check-Cap (MBAI) posted Net Income towards Common Stockholders of $29.2 million for Q4 2024, up 147.37% sequentially from -$61.8 million in Q4 2023, and up 147.37% YoY from $11.8 million in Q1 2024.
Check-Cap (MBAI) Net Income towards Common Stockholders (2014 - 2024) Analysis & Trends
Check-Cap has reported Net Income towards Common Stockholders for 11 years, with the latest figure at $29.2 million in Q4 2024.
- Quarterly Net Income towards Common Stockholders rose 147.37% year-over-year to $29.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $29.2 million (up 197.78% YoY) and the FY2025 annual result came in at $507851.0, up 46534.62% from the prior year.
- Net Income towards Common Stockholders advanced to $29.2 million in Q4 2024 per MBAI's latest filing, from -$61.8 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $29.2 million in Q4 2024 and troughed at -$61.8 million in Q4 2023.
- A 5-year average of $997904.8 and a median of $3.6 million in 2020 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders soared 1266.67% in 2022, then plunged 1569.19% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at $3.9 million in 2020, then jumped by 41.49% to $5.5 million in 2021, then slipped by 24.01% to $4.2 million in 2022, then slumped by 1569.19% to -$61.8 million in 2023, then soared by 147.37% to $29.2 million in 2024.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $29.2 million, -$61.8 million, and $2.6 million for Q4 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Check-Cap | 5.89 Mn | -793.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.38 Bn |
| Dec 31, 2023 | -34.49 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 6.88 Mn |
| Mar 31, 2023 | 4.85 Mn |
| Dec 31, 2022 | 4.22 Mn |
| Sep 30, 2022 | 4.75 Mn |
| Jun 30, 2022 | 4.81 Mn |
| Mar 31, 2022 | 5.89 Mn |
| Dec 31, 2021 | 5.58 Mn |
| Sep 30, 2021 | 4.24 Mn |
| Jun 30, 2021 | 3.92 Mn |
| Mar 31, 2021 | 3.57 Mn |
| Dec 31, 2020 | 3.91 Mn |
| Sep 30, 2020 | 3.62 Mn |
| Jun 30, 2020 | 2.89 Mn |
| Mar 31, 2020 | 3.43 Mn |
| Dec 31, 2019 | 3.83 Mn |
| Sep 30, 2019 | 3.50 Mn |
| Jun 30, 2019 | 3.36 Mn |